Rational use of psychotropic drugs. III. Major tranquilizers.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000661:Amphetamine / Q000506:poisoning; D000932:Antiemetics / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001833:Body Temperature Regulation / Q000187:drug effects; D002090:Butyrophenones / Q000627:therapeutic use; D004542:Ejaculation / Q000187:drug effects; D000431:Ethanol; D005334:Fever / Q000188:drug therapy; D006606:Hiccup / Q000188:drug therapy; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced; D009325:Nausea / Q000188:drug therapy; D010276:Parasympatholytics / Q000494:pharmacology; D010640:Phenothiazines; D010879:Piperazines / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D013892:Thioxanthenes / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014839:Vomiting / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D000932:Antiemetics; D014150:Antipsychotic Agents; D002090:Butyrophenones; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D010640:Phenothiazines; D010879:Piperazines; D013892:Thioxanthenes; D014149:Tranquilizing Agents; D000431:Ethanol; D000661:Amphetamine